<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00805870</url>
  </required_header>
  <id_info>
    <org_study_id>08-02-31</org_study_id>
    <nct_id>NCT00805870</nct_id>
  </id_info>
  <brief_title>The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers</brief_title>
  <official_title>The Effects of High Dose Fish Oil Supplementation on Delayed Onset Muscle Soreness and Inflammatory Markers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Western Michigan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Western Michigan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effects of fish oil supplementation (Lovaza,
      GlaxoSmithKline) on muscle strength, muscle soreness and inflammation following exercise.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      When a person exercises at a high intensity or starts a new exercise program, muscle soreness
      will develop. Muscle soreness that peaks between 24-72 hours after exercise and diminishes in
      5-7 days is characterized as delayed onset muscle soreness (DOMS). DOMS is associated with
      the eccentric phase of exercise, where the muscle is actively creating force while
      lengthening. The onset of muscle soreness is part of an inflammatory response due to the
      muscular damage caused by the exercise.

      Research has shown that fish oils have anti-inflammatory properties. Direct intake of various
      polyunsaturated fatty acids (PUFA) alters the cell membrane fatty acid composition, which, in
      turn modulates cell/tissue response to infection, injury and inflammatory events. These
      properties may be beneficial to relieve muscle soreness.

      Therefore, the purpose of this study is to determine the effects of fish oil supplementation
      (Lovaza, GlaxoSmithKline, 3 grams per day for 65 days) on muscle strength, muscle soreness
      and inflammation following exercise.

      Participants will be randomly assigned to one of two groups: Lovaza (3 grams/day) or placebo.
      Participants will consume either the Lovaza or the placebo for 65 consecutive days. On Day
      60, participants will have baseline measurements of muscle strength, muscle soreness,
      creatine kinase activity, and muscle inflammatory marker assessed. Participants will then
      perform eccentric exercise on an isokinetic dynamometer using the quadriceps muscles in order
      to induce muscle soreness. On each of Days 61-65, muscle strength, muscle soreness, creatine
      kinase activity, and muscle inflammatory markers will again be assessed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quadriceps Muscle Strength</measure>
    <time_frame>6 days</time_frame>
    <description>Quadriceps muscle strength is the maximal amount of force that the quadriceps muscles can produce during isometric knee extension exercise.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle Soreness of the Quadriceps Using an Algometer Strain Gauge</measure>
    <time_frame>6 days</time_frame>
    <description>The required amount of force applied to the quadriceps to elicit pain or discomfort.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Creatine Kinase Activity Measured in Blood</measure>
    <time_frame>6 days</time_frame>
    <description>Creatine kinase activity is an indirect indicator of muscle damage.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Interleukin-6 Measured in Blood</measure>
    <time_frame>6 days</time_frame>
    <description>Interleukin-6 is an indirect indicator of muscle inflammation.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Muscle Damage</condition>
  <condition>Muscle Inflammation</condition>
  <arm_group>
    <arm_group_label>Fish Oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lovaza, 3 grams/day for 65 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Wheat Germ Oil, 3 grams/day for 65 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lovaza (omega-3-acid ethyl esters)</intervention_name>
    <description>Lovaza, 3 grams per day for 65 days</description>
    <arm_group_label>Fish Oil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Wheat Germ Oil</intervention_name>
    <description>Wheat germ oil, 3 grams/day for 65 days</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy, free of disease

          -  Must be able to swallow capsules

          -  Free of orthopedic or muscular injuries

          -  Recreationally active

          -  Prior consumption of fish and corn with no adverse reactions

        Exclusion Criteria:

          -  Use of non-steroidal anti-inflammatory drugs (NSAIDS) or topical analgesics during
             study enrollment

          -  Pregnant or nursing

          -  Food allergy to fish or any components of the pills which includes alpha tocopherol,
             partially hydrogenated vegetable oils including soybean oils and gelatin and glycerol
             or wheat germ oil

          -  Competitive athlete or physically active more than 10 hours per week
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher C Cheatham, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Western Michigan University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Western Michigan University</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49008</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2008</study_first_submitted>
  <study_first_submitted_qc>December 9, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2008</study_first_posted>
  <results_first_submitted>August 11, 2011</results_first_submitted>
  <results_first_submitted_qc>August 1, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 5, 2012</results_first_posted>
  <last_update_submitted>August 1, 2012</last_update_submitted>
  <last_update_submitted_qc>August 1, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 5, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Western Michigan University</investigator_affiliation>
    <investigator_full_name>Christopher Cheatham</investigator_full_name>
    <investigator_title>Chair and Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Myalgia</mesh_term>
    <mesh_term>Myositis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Fish Oil</title>
          <description>Lovaza, 3 grams/day for 65 days</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Wheat Germ Oil, 3 grams/day for 65 days</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Fish Oil</title>
          <description>Lovaza, 3 grams/day for 65 days</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Wheat Germ Oil, 3 grams/day for 65 days</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="10"/>
            <count group_id="B3" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21.9" spread="1.7"/>
                    <measurement group_id="B2" value="23.4" spread="2.3"/>
                    <measurement group_id="B3" value="22.7" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Quadriceps Muscle Strength</title>
        <description>Quadriceps muscle strength is the maximal amount of force that the quadriceps muscles can produce during isometric knee extension exercise.</description>
        <time_frame>6 days</time_frame>
        <population>Number of subjects that completed the protocol. Analysis was per protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Fish Oil</title>
            <description>3 grams/day of fish oil for 65 days</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>3.45 grams/day of wheat germ oil for 65 days</description>
          </group>
        </group_list>
        <measure>
          <title>Quadriceps Muscle Strength</title>
          <description>Quadriceps muscle strength is the maximal amount of force that the quadriceps muscles can produce during isometric knee extension exercise.</description>
          <population>Number of subjects that completed the protocol. Analysis was per protocol.</population>
          <units>lbs</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="151" spread="6"/>
                    <measurement group_id="O2" value="160" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Null hypothesis is that no difference is observed in quadriceps muscle strength between the fish oil and control groups.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <method>ANOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>8.271</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>26.298</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-63.521</ci_lower_limit>
            <ci_upper_limit>46.978</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Muscle Soreness of the Quadriceps Using an Algometer Strain Gauge</title>
        <description>The required amount of force applied to the quadriceps to elicit pain or discomfort.</description>
        <time_frame>6 days</time_frame>
        <population>Number of subjects that completed the protocol. Analysis was per protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Fish Oil</title>
            <description>3 grams/day of fish oil for 65 days</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>3.45 grams/day of wheat germ oil for 65 days</description>
          </group>
        </group_list>
        <measure>
          <title>Muscle Soreness of the Quadriceps Using an Algometer Strain Gauge</title>
          <description>The required amount of force applied to the quadriceps to elicit pain or discomfort.</description>
          <population>Number of subjects that completed the protocol. Analysis was per protocol.</population>
          <units>lbs</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.62" spread="0.47"/>
                    <measurement group_id="O2" value="16.46" spread="0.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Null hypothesis is that there is no difference in the amount of force applied to the quadriceps to elicit pain or discomfort between the fish oil and control groups.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <method>ANOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-1.845</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>1.417</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.823</ci_lower_limit>
            <ci_upper_limit>1.132</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Creatine Kinase Activity Measured in Blood</title>
        <description>Creatine kinase activity is an indirect indicator of muscle damage.</description>
        <time_frame>6 days</time_frame>
        <population>Number of subjects that completed the protocol. Analysis was per protocol.</population>
        <group_list>
          <group group_id="O1">
            <title>Fish Oil</title>
            <description>3 grams/day of fish oil for 65 days</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>3.45 grams/day of wheat germ oil for 65 days</description>
          </group>
        </group_list>
        <measure>
          <title>Creatine Kinase Activity Measured in Blood</title>
          <description>Creatine kinase activity is an indirect indicator of muscle damage.</description>
          <population>Number of subjects that completed the protocol. Analysis was per protocol.</population>
          <units>IU/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="110.20" spread="11.81"/>
                    <measurement group_id="O2" value="167.21" spread="15.18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Null hypothesis is that there is no difference in creatine kinase activity between the fish oil and the control groups.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <method>ANOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-57.015</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>47.093</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-156.373</ci_lower_limit>
            <ci_upper_limit>42.344</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Interleukin-6 Measured in Blood</title>
        <description>Interleukin-6 is an indirect indicator of muscle inflammation.</description>
        <time_frame>6 days</time_frame>
        <population>Number of subjects that completed the protocol. Analysis was per protocol</population>
        <group_list>
          <group group_id="O1">
            <title>Fish Oil</title>
            <description>3 grams/day of fish oil for 65 days</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>3.45 grams/day of wheat germ oil for 65 days</description>
          </group>
        </group_list>
        <measure>
          <title>Interleukin-6 Measured in Blood</title>
          <description>Interleukin-6 is an indirect indicator of muscle inflammation.</description>
          <population>Number of subjects that completed the protocol. Analysis was per protocol</population>
          <units>pg/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="10"/>
                <count group_id="O2" value="10"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.23" spread="0.07"/>
                    <measurement group_id="O2" value="0.21" spread="0.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis is that there is no difference in interleukin-6 concentration between the fish oil and control groups.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <method>ANOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>0.022</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.188</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.374</ci_lower_limit>
            <ci_upper_limit>0.417</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Fish Oil</title>
          <description>Lovaza, 3 grams/day for 65 days</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Wheat Germ Oil, 3 grams/day for 65 days</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="10"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Christopher C. Cheatham</name_or_title>
      <organization>Western Michigan University</organization>
      <phone>269-387-2542</phone>
      <email>chris.cheatham@wmich.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

